Evan L. Russo
Known title: Chief Financial OfficerCIK: 0001717489
Associated companies
Transaction History
| LAZ | ▼ Sell | Open Market | 50,000 | $2.8M | 9/11/2025 | View on chart |
| LAZ | ▼ Sell | Open Market | 25,000 | $1.4M | 9/10/2025 | View on chart |
| LAZ | ▼ Sell | Gift | 15,000 | $0 | 9/9/2025 | View on chart |
| LAZ | ▲ Buy | Option Exercise | 254,467 | — | 3/13/2025 | View on chart |
| LAZ | ▼ Sell | Other | 100,000 | $4.5M | 3/13/2025 | View on chart |
| LAZ | ▼ Sell | Open Market | 25,000 | $1.4M | 2/14/2025 | View on chart |
| LAZ | ▼ Sell | Open Market | 15,000 | $810K | 2/13/2025 | View on chart |
| LAZ | ▼ Sell | Open Market | 35,000 | $1.9M | 2/12/2025 | View on chart |
| LAZ | ▼ Sell | Open Market | 50,000 | $2.7M | 2/12/2025 | View on chart |
| LAZ | ▼ Sell | Gift | 4,000 | $0 | 12/13/2024 | View on chart |
| LAZ | ▼ Sell | Open Market | 75,000 | $3.0M | 3/13/2024 | View on chart |
| LAZ | ▲ Buy | Option Exercise | 168,539 | — | 3/11/2024 | View on chart |
| LAZ | ▼ Sell | Other | 75,000 | $2.9M | 3/11/2024 | View on chart |
| LAZ | ▼ Sell | Gift | 4,000 | $0 | 12/26/2023 | View on chart |
| LAZ | ▼ Sell | Other | 56,917 | $2.1M | 3/8/2023 | View on chart |
| LAZ | ▲ Buy | Option Exercise | 134,696 | — | 3/8/2023 | View on chart |
| LAZ | ▼ Sell | Gift | 4,000 | $0 | 11/25/2022 | View on chart |
| LAZ | ▲ Buy | Option Exercise | 108,969 | — | 3/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Lazard faces lowered price targets from Morgan Stanley and UBS
Morgan Stanley and UBS recently cut their price targets for Lazard to $41 and $40, respectively, while maintaining Underweight and Neutral ratings. This move aligns with broader market concerns about rising bond yields and the firm's high 7.25% dividend yield, which some analysts view as stretched. The stock is currently trading near its support level, reflecting the cautious sentiment from these recent analyst actions.
Lazard faces lowered price targets from Morgan Stanley and UBS. Morgan Stanley and UBS recently cut their price targets for Lazard to $41 and $40, respectively, while maintaining Underweight and Neutral ratings. This move aligns with broader market concerns about rising bond yields and the firm's high 7.25% dividend yield, which some analysts view as stretched. The stock is currently trading near its support level, reflecting the cautious sentiment from these recent analyst actions.